Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBDBee is a United Kingdom-based wellness company and digital marketplace dedicated to the distribution of cannabidiol (CBD) and hemp-derived products. The company serves as a curated platform, offering a diverse range of items including CBD oils, capsules, gummies, topicals, and vaping accessories from various reputable brands. CBDBee focuses on the consumer healthcare sector, positioning its products as natural supplements for managing conditions such as anxiety, chronic pain, and sleep disturbances. A key aspect of their business model is ensuring product quality and transparency by providing access to third-party laboratory testing results for the brands they host. By aggregating high-quality cannabinoid products, CBDBee aims to simplify the purchasing process for health-conscious consumers seeking alternative wellness solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBDBee.